Skip to main content

Regulation of Extrarenal Vitamin D Metabolism as a Tool for Colon and Prostate Cancer Prevention

  • Conference paper
Vitamin D Analogs in Cancer Prevention and Therapy

Part of the book series: Recent Results in Cancer Research ((RECENTCANCER,volume 164))

Abstract

Though 1,25-dihydroxyvitamin D3(1,25-D3) as well as some vitamin D analogs have an antimitotic as well as a differentiating action, therapeutic application in tumor patients is still precluded due to their hypercalcemic action at the necessary concentration. Our observation that early during progression, colon tumor cells express CYP27B1, the enzyme essential for 1,25-D3 synthesis, as well as the vitamin D receptor (VDR) at a higher level than normal colon cells led to the speculation that, by induction of this expression, a physiological defense against tumor progression could be activated and enhanced. In some Asian countries where soy products are a main staple, prostate and breast tumor incidence is extremely low. We speculated that this could be due to regulation of CYP enzymes by phytoestrogens present in soy such as genistein. In prostate tumor cells, the 1,25-dihydroxyvitamin D3catabolizing enzyme CYP24 is frequently highly expressed. We were able to demonstrate that genistein down-regulates expression of CYP24 to almost nil, which would result in enhancement of local 1,25-D3 levels and improved mitotic control of tumor cells.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Akiyama T, Ishida J, Nakagawa S, Ogawara H, Watanabe S, Itoh N, Shibuya M, Fukami Y (1987) Genistein, a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem 262:5592–5595

    PubMed  CAS  Google Scholar 

  • Albertson DG, Ylstra B, Segraves R, Collins C, Dairkee SH, Kowbel D, Kuo WL, Gray J W, Pinkel D (2000) Quantitative mapping of amplicon structure by array CGH identifies CYP24 as a candidate oncogene. Nat Genet 25:144–146

    Article  PubMed  CAS  Google Scholar 

  • Bareis P, Bises G, Bischof MG, Cross HS, Peterlik M (2001) 25-hydroxyvitamin D metabolism in human colon cancer cells during tumor progression. Biochem Biophys Res Commun 285:1012–1017

    Article  PubMed  CAS  Google Scholar 

  • Bareis P, Kallay E, Bischof MG, Bises G, Hofer H, Põtzi C, Manhardt T, Bland R, Cross HS (2002) Clonal differences in expression of 25-hydroxyvitamin D3–1a-hydroxylase, of 25-hydroxyvitamin D3–24-hydroxylase, and of the vitamin D receptor in human colon carcinoma cells: effects of epidermal growth factor and 1a,25-dihydroxyvitamin D3. Exp CellRes 276:320–327

    Article  CAS  Google Scholar 

  • Corder EH, Guess HA, Hulka BS, Friedman GD, Sadler M, Vollmer RT, Lobaugh B, Drezner MK, Vogelman JH, Orentreich N (1993) Vitamin D and prostate cancer: a prediagnostic study with stored sera. Cancer Epidemiol Biomarkers Prev 2:467–472

    PubMed  CAS  Google Scholar 

  • Cross HS, Pavelka M, Slavik J, Peterlik M (1992) Growth control of human colon cancer cells by vitamin D and calcium in vitro. J Natl Cancer Inst 84:1355–1357

    Article  PubMed  CAS  Google Scholar 

  • Cross HS, Peterlik M, Reddy GS, Schuster I (1997) Vitamin D metabolism in human colon adenocarcinoma-derived Caco-2 cells: expression of 25-hydroxyvitamin D3–1a-hydroxylase activity and regulation of side chain metabolism. J Steroid Biochem Mol Biol 62:21–28

    Article  PubMed  CAS  Google Scholar 

  • Cross HS, Bareis P, Hofer H, Bischof MG, Bajna E, Kriwanek S, Bonner E, Peterlik M (2001) 25-hydroxyvitamin D3–1a-hydroxylase and vitamin D receptor gene expression in human colonic mucosa is elevated during early cancerogenesis. Steroids 66:287–292

    Article  PubMed  CAS  Google Scholar 

  • Farhan H, Wõhõlõ K, Adlercreutz H, Cross HS (2002) Isoflavonoids inhibit catabolism of vitamin D in prostate cancer cells. J Chromatography B 777:261–268

    Article  CAS  Google Scholar 

  • Garland CF, Garland FC (1980) Do sunlight and vitamin D reduce the likelihood of colon cancer? Int J Epidemiol 9:227–231

    Article  PubMed  CAS  Google Scholar 

  • Garland FC, Garland CF, Gorham ED, Young J F (1990) Geographic variation in breast cancer mortality in the United States: a hypothesis involving exposure to solar radiation. Prev Med 19:614–622

    Article  PubMed  CAS  Google Scholar 

  • Grant WB (2002) An estimate of premature cancer mortality in the United States due to inadequate doses of solar ultraviolet-B radiation. Cancer 94:1867–1875

    Article  PubMed  Google Scholar 

  • Hanchette CL, Schwartz GG (1992) Geographic patterns of prostate cancer mortality. Evidence for a protective effect of ultraviolet radiation. Cancer 70:2861–2869

    Article  PubMed  CAS  Google Scholar 

  • Hofer H, Ho G-M, Peterlik M, Uskokovic MR, Lee JK, White MC, Posner, Cross HS (1999) Biological effects of 1a-hydroxy-and 1b-(hydroxymethyl)-vitamin D compounds relevant for potential colorectal cancer therapy. J Pharmacol Exp Ther 291:450–455

    PubMed  CAS  Google Scholar 

  • Kallay E, Pietschmann P, Toyokuni S, Bajna E, Hahn P, Mazzucco K, Bieglmayer C, Kato S, Cross HS (2001) Characterization of a vitamin D receptor knockout mouse as a model ofcolorectal hyperproliferation and DNA damage. Carcinogenesis 22:1429–1435

    Article  PubMed  CAS  Google Scholar 

  • Krege JH, Hodgin JB, Couse JF, Enmark E, Warner M, Mahler JF, Sar M, Korach KS, Gustafson JA, Smithies O (1998) Generation and reproductive phenotypes of mice lacking estrogen receptor b. Proc Natl Acad Sci U S A 95:15677–15682

    Article  PubMed  CAS  Google Scholar 

  • Kuiper GJM, Lemmen JG, Carlsson B, Corton JC, Safe SH, van der Saag PT, van der Burg B, Gustafsson JA (1998) Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor b. Endocrinol 139:4252–4263

    Article  CAS  Google Scholar 

  • Lau KM, LaSpina M, Long J, Ho SM (2000) Expression of estrogen receptor (ER)-a and ER-bin normal and malignant prostatic epithelial cells: regulation by methylation and involvementin growth regulation. Cancer Res 60:3175–3182

    PubMed  CAS  Google Scholar 

  • Ly LH, Zhao X-Y, Holloway L, Feldman D (1999) Liarozole acts synergistically with 1,25-dihydroxyvitamin D3 to inhibit growth of DU 145 human prostate cancer cells by blocking 24-hydroxylase activity. Endocrinology 140:2071–2076

    Article  PubMed  CAS  Google Scholar 

  • Markovits J, Linassier C, Fosse P, Couprie J, Pierre J, Jacquemin-Sablon A, Saucier JM, Le Pecq JB, Larsen AK (1989) Inhibitory effects of the tyrosine kinase inhibitor genistein on mammalian DNA topoisomerase II. Cancer Res. 49:5111–5117

    PubMed  CAS  Google Scholar 

  • Nesby-O_Dell S, Scanlon KS, Cogswell ME, Gillespie C, Hollis BW, Looker AC, Allen C, Doughertly C, Gunter EW, Bowman BA (2002) Hypovitaminosis D prevalence and determinants among African American and white women of reproductive age: third National Health and Nutrition Examination Survey, 1988–1994. Am J Clin Nutr 76:187–192

    CAS  Google Scholar 

  • Schwartz GG, Whitlatch LW, Chen TC, Lokeshwar BL, Holick MF (1998) Human prostate cells synthesize 1,25-dihydroxyvitamin D3 from 25-hydroxyvitamin D3. Cancer Epidemiol Biomarkers Prev 7:391–395

    PubMed  CAS  Google Scholar 

  • Sheinin Y, Kaserer K, Wrba F, Wenzl E, Kriwanek S, Peterlik M, Cross HS (2000) In situ mRNA hybridization analysis and immunolocalization of the vitamin D receptor in normal and carcinomatous human colonic mucosa: relation to epidermal growth factor receptor expression. Virchows Arch 437:501–507

    Article  PubMed  CAS  Google Scholar 

  • Smirnoff P, Liel Y, Gnainsky J, Shany S, Schwartz B (1999) The protective effect of estrogen against chemically induced murine colon carcinogenesis is associated with decreased CpG island methylation and increased mRNA and protein expression of the colonic vitamin D receptor. Oncol Res 11: 255–264

    PubMed  CAS  Google Scholar 

  • Swami S, Krishnan AV, Feldman D (2000) 1alpha,25-Dihydroxyvitamin D3 down-regulates estrogen receptor abundance and suppresses estrogen actions in MCF-7 human breast cancer cells. Clin Cancer Res 6:3371–3379

    PubMed  CAS  Google Scholar 

  • Tuohimaa P, Lyakhovich A, Aksenov N, Pennanen P, Syvala H, Lou YR, Ahonen M, Hasan T, Pasanen P, Blauer M et al (2001) Vitamin D and prostate cancer. J Steroid Biochem Mol Biol 76:125–134

    Article  PubMed  CAS  Google Scholar 

  • World Cancer Research Fund and American Institute for Cancer Research (1997) Food, nutrition and the prevention of cancer: a global perspective. World Cancer Research Fund and American Institute for Cancer Research, Washington, DC

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2003 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Cross, H.S., Kállay, E., Farhan, H., Weiland, T., Manhardt, T. (2003). Regulation of Extrarenal Vitamin D Metabolism as a Tool for Colon and Prostate Cancer Prevention. In: Reichrath, J., Tilgen, W., Friedrich, M. (eds) Vitamin D Analogs in Cancer Prevention and Therapy. Recent Results in Cancer Research, vol 164. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-55580-0_30

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-55580-0_30

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-62435-3

  • Online ISBN: 978-3-642-55580-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics